OVIT — OncoVista Innovative Therapies Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for OncoVista Innovative Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2010 December 31st	2011 December 31st	2012 December 31st	2013 December 31st	2014 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	3.52	2.13	0.512	0.045	0.013
Net Total Accounts Receivable
Net Total Receivables	0.007	0	—	—	—
Total Inventory
Prepaid Expenses
Total Current Assets	3.53	2.18	0.572	0.096	0.013
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.016	0.01	0.003	0	0
Other Long Term Assets
Total Assets	3.55	2.19	0.575	0.096	0.013
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1.89	2.31	2.25	3.22	4.98
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Liabilities	1.89	2.31	2.25	3.22	5.68
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1.66	-0.124	-1.68	-3.12	-5.66
Total Liabilities & Shareholders' Equity	3.55	2.19	0.575	0.096	0.013
Total Common Shares Outstanding